← All Sponsors
SPONSOR

Nanfang Hospital, Southern Medical University

Total Trials
14
Recruiting
14
Phases
Phase 4, Phase 3, Phase 2

Nanfang Hospital, Southern Medical University is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Anesthesia, Surgery-Complications, Newly Diagnosed Acute Myeloid Leukemia With High Risk, Root Canal Infection.

The trial portfolio spans Phase 4, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Nanfang Hospital, Southern Medical University

How many clinical trials has Nanfang Hospital, Southern Medical University sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Nanfang Hospital, Southern Medical University, of which 14 are actively recruiting participants. These trials cover conditions including Anesthesia, Surgery-Complications, Newly Diagnosed Acute Myeloid Leukemia With High Risk. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanfang Hospital, Southern Medical University research focus on?
Nanfang Hospital, Southern Medical University clinical trials span Anesthesia, Surgery-Complications, Newly Diagnosed Acute Myeloid Leukemia With High Risk, Root Canal Infection, Tooth Defect, and additional conditions. The research pipeline includes Phase 4, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nanfang Hospital, Southern Medical University clinical trial?
To participate in a Nanfang Hospital, Southern Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanfang Hospital, Southern Medical University trials with current recruitment status updated daily.

Clinical Trials by Nanfang Hospital, Southern Medical University

NCT05728775 Phase 4
Recruiting

REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry

Anesthesia
NCT06810791 Phase 3
Recruiting

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Newly Diagnosed Acute Myeloid Leukemia With High Risk
NCT07206108
Recruiting

Clinical Trial of Modified Endocrown and Personalized Post-core and Crown for Large-area Tooth Defects After Root Canal Treatment

Root Canal Infection
NCT03919552 Phase 3
Recruiting

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Cisplatin
NCT06173947
Recruiting

SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury

End Stage Liver Disease
NCT07157618
Recruiting

Prospective Pathology Foundation Models

Pancancer
NCT04916457
Recruiting

The Role of Skin Microecology in Diabetic Skin Lesions

Diabetic Foot
NCT06817239
Recruiting

Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT)

Delirium in Old Age
NCT07762573
Recruiting

Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study

Chronic Obstructive Pulmonary Disease
NCT06177925 Phase 2
Recruiting

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Respiratory Tract Neoplasms
NCT06307327
Recruiting

Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis

Head and Neck Cancer
NCT05316103
Recruiting

Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy

Rectal Cancer
NCT05977283
Recruiting

HBsAg Declined Patients Follow-up Study

Hepatitis B
NCT06039696
Recruiting

Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection

Cirrhosis, Liver
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology